Cargando…

FDA approved vaccines for monkeypox: Current eminence

Detalles Bibliográficos
Autores principales:	Chopra, Hitesh, Dhawan, Manish, Bibi, Shabana, Baig, Atif Amin, Kushwah, Ajay Singh, Kaur, Manpreet, Emran, Talha Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628798/ https://www.ncbi.nlm.nih.gov/pubmed/36089263 http://dx.doi.org/10.1016/j.ijsu.2022.106896

Ejemplares similares

Recent outbreak of monkeypox: Overview of signs, symptoms, preventive measures, and guideline for supportive management
por: Shuvo, Pollob Ahmed, et al.
Publicado: (2022)

Robotics in surgery: Current trends
por: Chopra, Hitesh, et al.
Publicado: (2022)

Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment
por: Chakrabartty, Ishani, et al.
Publicado: (2022)

Artificial intelligence in surgery: Modern trends – Correspondence
por: Chopra, Hitesh, et al.
Publicado: (2022)

The resurgence of monkeypox cases: Reasons, threat assessment, and possible preventive measures
por: Dhawan, Manish, et al.
Publicado: (2022)

Unusual spread of the monkeypox virus: An emerging threat to the public health and the possible containment
por: Islam, Fahadul, et al.
Publicado: (2022)

Green Metallic Nanoparticles: Biosynthesis to Applications
por: Chopra, Hitesh, et al.
Publicado: (2022)

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
por: Chopra, Hitesh, et al.
Publicado: (2022)

Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)

Modern drug discovery applications for the identification of novel candidates for COVID-19 infections
por: Rani, Isha, et al.
Publicado: (2022)

Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
por: Arasu, M.Valan, et al.
Publicado: (2023)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs
por: Sahoo, Ajaya Kumar, et al.
Publicado: (2022)

Neuropsychiatric manifestations of monkeypox: A clinically oriented comprehensive review
por: Sethi, Yashendra, et al.
Publicado: (2023)

Monkeypox from Congo 1970 to Europe 2022; is there a difference?
por: Khaity, Abdulrhman, et al.
Publicado: (2022)

Current FDA-Approved Therapies for High-Grade Malignant Gliomas
por: Fisher, Jacob P., et al.
Publicado: (2021)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Langya virus: Slope of the iceberg for unexplored pathogens
por: Amin, Ruhul, et al.
Publicado: (2023)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy
por: Wang, Jia, et al.
Publicado: (2022)

Reverse zoonosis and its relevance to the monkeypox outbreak 2022
por: Choudhary, Om Prakash, et al.
Publicado: (2022)

Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study
por: Srivastava, Varshita, et al.
Publicado: (2023)

Autophagy and Alzheimer’s disease: How far science has to be progressed? − correspondence
por: Emran, Talha B., et al.
Publicado: (2023)

Leprosy: an ancient infectious disease with unresolved complications
por: Chopra, Hitesh, et al.
Publicado: (2023)

Re-emergence of Rift Valley fever: an update and preventive measures
por: Chopra, Hitesh, et al.
Publicado: (2023)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
por: Tshiani Mbaya, Olivier, et al.
Publicado: (2021)

The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point
por: Eiser, Arnold R.
Publicado: (2021)

Novel insights on the role of VCAM-1 and ICAM-1: Potential biomarkers for cardiovascular diseases
por: Kaur, Rupinder, et al.
Publicado: (2022)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

FDA-Approved Natural Polymers for Fast Dissolving Tablets
por: Alam, Md Tausif, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d0dke1nn8tk6mlh24kim0lb4je